The ovulation testing kits market size has grown rapidly in recent years. It will grow from $3.32 billion in 2025 to $3.66 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to growing awareness of fertility planning, increasing prevalence of delayed pregnancies, expansion of home diagnostic product availability, rising adoption of self-testing healthcare devices, improvements in hormone detection technologies.
The ovulation testing kits market size is expected to see strong growth in the next few years. It will grow to $5.19 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing demand for connected fertility solutions, rising use of personalized reproductive health tools, expansion of e-commerce distribution for diagnostics, growing focus on women’s health management, increasing adoption of ai-enabled fertility tracking. Major trends in the forecast period include increasing adoption of digital ovulation testing kits, rising demand for home-based fertility monitoring, growing integration of mobile apps with testing kits, expansion of disposable and user-friendly test formats, enhanced focus on accuracy and early fertility detection.
The decline in fertility rates is expected to drive the growth of the ovulation testing kits market. Fertility rates refer to the number of live births within a population over a specific period, typically expressed as the number of births per 1,000 women of childbearing age (usually aged 15-49) in a year. The decrease in fertility rates is influenced by factors such as greater education and career opportunities for women, better access to and use of contraceptives, delayed marriage and childbearing, and high living costs. Ovulation testing kits are valuable tools for individuals or couples experiencing low fertility rates, offering a non-invasive and accessible way to optimize the timing of intercourse and increase the chances of conception. For example, according to the Office for National Statistics, a UK-based governmental organization, the total fertility rate (TFR) in England and Wales decreased from 1.49 children per woman in 2022 to 1.44 in 2023, the lowest rate on record. As a result, declining fertility rates are contributing to the growth of the ovulation testing kits market.
Leading companies in the ovulation testing kits market are focusing on developing advanced solutions, such as multi-hormone at-home testing systems, to replace traditional single-hormone ovulation test strips. A multi-hormone solution is an innovative fertility-monitoring technology that improves accuracy by simultaneously measuring several key reproductive hormones, offering deeper insights into ovulation timing, cycle health, and overall fertility. For example, in August 2025, Mira, a US-based women’s health technology company, launched Ultra4, the first at-home hormone monitor with lab-quality 4-in-1 testing. This solution replaces conventional ovulation kits by measuring four essential fertility hormones - FSH, E3G, LH, and PdG - using a fluorescent-based system that delivers precise, quantitative results. It provides real-time hormone tracking, advanced cycle insights, and new features such as 4D Ovulation Profiling, which assesses ovulation timing, strength, and viability. Integrated with the Mira App, Ultra4™ enables users to visualize hormone patterns, receive personalized fertility predictions, and gain a deeper understanding of their reproductive health. The Ultra4 enhances conception planning, improves diagnostic clarity, and empowers users with comprehensive, data-driven fertility monitoring at home.
In December 2023, Biogenes Technologies Sdn Bhd, a Malaysia-based biotechnology company, acquired Allen Healthcare Products for an undisclosed sum. This strategic acquisition is intended to boost Biogenes Technologies' production capacity for diagnostic test kits, enhance its research capabilities, and expand its footprint in the Southeast Asian market. Allen Healthcare Products, also based in Malaysia, specializes in rapid test kits, including ovulation test kits.
Major companies operating in the ovulation testing kits market are Church And Dwight Co Inc, Piramal Enterprises Inc., Meril Diagnostics Pvt Ltd, BIOSYNEX SA, Boditech Med Inc., Mankind Pharma Ltd., Innovita Biological Technology Co. Ltd., Hangzhou Clongene Biotech Co. Ltd., Swiss Precision Diagnostics GmbH, Artron Laboratories Inc., Wondfo Biotech Co. Ltd., AdvaCare Pharma, Proov, Shanghai Chemtron Biotech Co. Ltd., Ava Science Inc., Clinical Guard Ltd., Fairhaven Health LLC, Femometer Ltd., Easy Healthcare Corporation (Premom), Tulip Diagnostics Pvt. Ltd.
North America was the largest region in the ovulation testing kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ovulation testing kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ovulation testing kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the ovulation testing kits market by increasing costs of imported biochemical reagents, diagnostic strips, electronic readers, packaging materials, and plastic components used in urine-based and digital test kits. Manufacturers in North America and Europe are most affected due to reliance on globally sourced consumables, while Asia-Pacific faces pricing pressures in mass production and export of testing kits. These tariffs are raising production costs and influencing retail pricing strategies. However, they are also encouraging regional manufacturing, local sourcing of reagents, and innovation in cost-efficient test designs, supporting long-term market stability.
The ovulation testing kits market research report is one of a series of new reports that provides ovulation testing kits market statistics, including ovulation testing kits industry global market size, regional shares, competitors with a ovulation testing kits market share, detailed ovulation testing kits market segments, market trends and opportunities, and any further data you may need to thrive in the ovulation testing kits industry. This ovulation testing kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Ovulation testing kits are diagnostic devices crafted to assist individuals in pinpointing the most fertile days of their menstrual cycle by detecting the surge in luteinizing hormone (LH) that occurs before ovulation. These kits are frequently employed by couples seeking to conceive to determine the best timing for intercourse, thereby enhancing the chances of pregnancy. Serving as valuable aids in family planning, these kits provide a non-intrusive and simple means to comprehend and leverage the body's natural fertility cues.
The primary categories of ovulation testing kits include urine-based, saliva-based, and salivary ferning kits. Urine-based kits utilize hormonal changes in urine to forecast ovulation. They are available through various distribution channels such as pharmacies, drugstores, hypermarkets, supermarkets, e-commerce platforms, and others. These kits cater to diverse end users including hospitals, clinics, diagnostic centers, fertility centers, home care settings, and others.
The ovulation testing kits market consists of sales of digital ovulation predictor kits, combination kits, fertility monitors, and ovulation prediction wearables. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The ovulation testing kits market size is expected to see strong growth in the next few years. It will grow to $5.19 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing demand for connected fertility solutions, rising use of personalized reproductive health tools, expansion of e-commerce distribution for diagnostics, growing focus on women’s health management, increasing adoption of ai-enabled fertility tracking. Major trends in the forecast period include increasing adoption of digital ovulation testing kits, rising demand for home-based fertility monitoring, growing integration of mobile apps with testing kits, expansion of disposable and user-friendly test formats, enhanced focus on accuracy and early fertility detection.
The decline in fertility rates is expected to drive the growth of the ovulation testing kits market. Fertility rates refer to the number of live births within a population over a specific period, typically expressed as the number of births per 1,000 women of childbearing age (usually aged 15-49) in a year. The decrease in fertility rates is influenced by factors such as greater education and career opportunities for women, better access to and use of contraceptives, delayed marriage and childbearing, and high living costs. Ovulation testing kits are valuable tools for individuals or couples experiencing low fertility rates, offering a non-invasive and accessible way to optimize the timing of intercourse and increase the chances of conception. For example, according to the Office for National Statistics, a UK-based governmental organization, the total fertility rate (TFR) in England and Wales decreased from 1.49 children per woman in 2022 to 1.44 in 2023, the lowest rate on record. As a result, declining fertility rates are contributing to the growth of the ovulation testing kits market.
Leading companies in the ovulation testing kits market are focusing on developing advanced solutions, such as multi-hormone at-home testing systems, to replace traditional single-hormone ovulation test strips. A multi-hormone solution is an innovative fertility-monitoring technology that improves accuracy by simultaneously measuring several key reproductive hormones, offering deeper insights into ovulation timing, cycle health, and overall fertility. For example, in August 2025, Mira, a US-based women’s health technology company, launched Ultra4, the first at-home hormone monitor with lab-quality 4-in-1 testing. This solution replaces conventional ovulation kits by measuring four essential fertility hormones - FSH, E3G, LH, and PdG - using a fluorescent-based system that delivers precise, quantitative results. It provides real-time hormone tracking, advanced cycle insights, and new features such as 4D Ovulation Profiling, which assesses ovulation timing, strength, and viability. Integrated with the Mira App, Ultra4™ enables users to visualize hormone patterns, receive personalized fertility predictions, and gain a deeper understanding of their reproductive health. The Ultra4 enhances conception planning, improves diagnostic clarity, and empowers users with comprehensive, data-driven fertility monitoring at home.
In December 2023, Biogenes Technologies Sdn Bhd, a Malaysia-based biotechnology company, acquired Allen Healthcare Products for an undisclosed sum. This strategic acquisition is intended to boost Biogenes Technologies' production capacity for diagnostic test kits, enhance its research capabilities, and expand its footprint in the Southeast Asian market. Allen Healthcare Products, also based in Malaysia, specializes in rapid test kits, including ovulation test kits.
Major companies operating in the ovulation testing kits market are Church And Dwight Co Inc, Piramal Enterprises Inc., Meril Diagnostics Pvt Ltd, BIOSYNEX SA, Boditech Med Inc., Mankind Pharma Ltd., Innovita Biological Technology Co. Ltd., Hangzhou Clongene Biotech Co. Ltd., Swiss Precision Diagnostics GmbH, Artron Laboratories Inc., Wondfo Biotech Co. Ltd., AdvaCare Pharma, Proov, Shanghai Chemtron Biotech Co. Ltd., Ava Science Inc., Clinical Guard Ltd., Fairhaven Health LLC, Femometer Ltd., Easy Healthcare Corporation (Premom), Tulip Diagnostics Pvt. Ltd.
North America was the largest region in the ovulation testing kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ovulation testing kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ovulation testing kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the ovulation testing kits market by increasing costs of imported biochemical reagents, diagnostic strips, electronic readers, packaging materials, and plastic components used in urine-based and digital test kits. Manufacturers in North America and Europe are most affected due to reliance on globally sourced consumables, while Asia-Pacific faces pricing pressures in mass production and export of testing kits. These tariffs are raising production costs and influencing retail pricing strategies. However, they are also encouraging regional manufacturing, local sourcing of reagents, and innovation in cost-efficient test designs, supporting long-term market stability.
The ovulation testing kits market research report is one of a series of new reports that provides ovulation testing kits market statistics, including ovulation testing kits industry global market size, regional shares, competitors with a ovulation testing kits market share, detailed ovulation testing kits market segments, market trends and opportunities, and any further data you may need to thrive in the ovulation testing kits industry. This ovulation testing kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Ovulation testing kits are diagnostic devices crafted to assist individuals in pinpointing the most fertile days of their menstrual cycle by detecting the surge in luteinizing hormone (LH) that occurs before ovulation. These kits are frequently employed by couples seeking to conceive to determine the best timing for intercourse, thereby enhancing the chances of pregnancy. Serving as valuable aids in family planning, these kits provide a non-intrusive and simple means to comprehend and leverage the body's natural fertility cues.
The primary categories of ovulation testing kits include urine-based, saliva-based, and salivary ferning kits. Urine-based kits utilize hormonal changes in urine to forecast ovulation. They are available through various distribution channels such as pharmacies, drugstores, hypermarkets, supermarkets, e-commerce platforms, and others. These kits cater to diverse end users including hospitals, clinics, diagnostic centers, fertility centers, home care settings, and others.
The ovulation testing kits market consists of sales of digital ovulation predictor kits, combination kits, fertility monitors, and ovulation prediction wearables. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Ovulation Testing Kits Market Characteristics
3. Ovulation Testing Kits Market Supply Chain Analysis
4. Global Ovulation Testing Kits Market Trends and Strategies
5. Ovulation Testing Kits Market Analysis of End Use Industries
7. Global Ovulation Testing Kits Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Ovulation Testing Kits Total Addressable Market (TAM) Analysis for the Market
9. Ovulation Testing Kits Market Segmentation
10. Ovulation Testing Kits Market Regional and Country Analysis
11. Asia-Pacific Ovulation Testing Kits Market
12. China Ovulation Testing Kits Market
13. India Ovulation Testing Kits Market
14. Japan Ovulation Testing Kits Market
15. Australia Ovulation Testing Kits Market
16. Indonesia Ovulation Testing Kits Market
17. South Korea Ovulation Testing Kits Market
18. Taiwan Ovulation Testing Kits Market
19. South East Asia Ovulation Testing Kits Market
20. Western Europe Ovulation Testing Kits Market
21. UK Ovulation Testing Kits Market
22. Germany Ovulation Testing Kits Market
23. France Ovulation Testing Kits Market
24. Italy Ovulation Testing Kits Market
25. Spain Ovulation Testing Kits Market
26. Eastern Europe Ovulation Testing Kits Market
27. Russia Ovulation Testing Kits Market
28. North America Ovulation Testing Kits Market
29. USA Ovulation Testing Kits Market
30. Canada Ovulation Testing Kits Market
31. South America Ovulation Testing Kits Market
32. Brazil Ovulation Testing Kits Market
33. Middle East Ovulation Testing Kits Market
34. Africa Ovulation Testing Kits Market
36. Ovulation Testing Kits Market Competitive Landscape and Company Profiles
37. Ovulation Testing Kits Market Other Major and Innovative Companies
40. Ovulation Testing Kits Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Ovulation Testing Kits Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses ovulation testing kits market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for ovulation testing kits? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ovulation testing kits market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Urine-Based; Saliva-Based; Salivary Ferning2) By Distribution Channel: Pharmacies And Drugstores; Hypermarkets And Supermarkets; E-Commerce; Other Distribution Channels
3) By End User: Hospitals; Clinics; Diagnostic Centers; Fertility Centers; Home Care Settings; Other End Uses
Subsegments:
1) By Urine-Based: Dipstick Tests; Midstream Tests; Digital Urine Tests2) By Saliva-Based: Saliva Ovulation Test Strips; Saliva Test Kits with Magnification
3) By Salivary Ferning: Ferning Microscopes; Ferning Test Kits
Companies Mentioned: Church And Dwight Co Inc; Piramal Enterprises Inc.; Meril Diagnostics Pvt Ltd; BIOSYNEX SA; Boditech Med Inc.; Mankind Pharma Ltd.; Innovita Biological Technology Co. Ltd.; Hangzhou Clongene Biotech Co. Ltd.; Swiss Precision Diagnostics GmbH; Artron Laboratories Inc.; Wondfo Biotech Co. Ltd.; AdvaCare Pharma; Proov; Shanghai Chemtron Biotech Co. Ltd.; Ava Science Inc.; Clinical Guard Ltd.; Fairhaven Health LLC; Femometer Ltd.; Easy Healthcare Corporation (Premom); Tulip Diagnostics Pvt. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Ovulation Testing Kits market report include:- Church And Dwight Co Inc
- Piramal Enterprises Inc.
- Meril Diagnostics Pvt Ltd
- BIOSYNEX SA
- Boditech Med Inc.
- Mankind Pharma Ltd.
- Innovita Biological Technology Co. Ltd.
- Hangzhou Clongene Biotech Co. Ltd.
- Swiss Precision Diagnostics GmbH
- Artron Laboratories Inc.
- Wondfo Biotech Co. Ltd.
- AdvaCare Pharma
- Proov
- Shanghai Chemtron Biotech Co. Ltd.
- Ava Science Inc.
- Clinical Guard Ltd.
- Fairhaven Health LLC
- Femometer Ltd.
- Easy Healthcare Corporation (Premom)
- Tulip Diagnostics Pvt. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.66 Billion |
| Forecasted Market Value ( USD | $ 5.19 Billion |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
